Julie E. Goodwin

2.0k total citations
39 papers, 1.4k citations indexed

About

Julie E. Goodwin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Julie E. Goodwin has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Genetics. Recurrent topics in Julie E. Goodwin's work include Hormonal Regulation and Hypertension (11 papers), Estrogen and related hormone effects (6 papers) and Ion Transport and Channel Regulation (5 papers). Julie E. Goodwin is often cited by papers focused on Hormonal Regulation and Hypertension (11 papers), Estrogen and related hormone effects (6 papers) and Ion Transport and Channel Regulation (5 papers). Julie E. Goodwin collaborates with scholars based in United States, Japan and China. Julie E. Goodwin's co-authors include Swayam Prakash Srivastava, David S. Geller, Keizo Kanasaki, Daisuke Koya, William C. Sessa, Heino Velázquez, Yan Feng, Tie‐Ning Zhang, Junhui Zhang and Bing Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Julie E. Goodwin

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie E. Goodwin United States 23 505 340 214 198 168 39 1.4k
Wenguang Feng United States 20 559 1.1× 209 0.6× 116 0.5× 145 0.7× 146 0.9× 41 1.5k
Guijun Qin China 24 553 1.1× 417 1.2× 208 1.0× 192 1.0× 426 2.5× 88 1.7k
Michiaki Abe Japan 20 310 0.6× 336 1.0× 233 1.1× 150 0.8× 131 0.8× 82 1.8k
Ling Yu China 20 420 0.8× 304 0.9× 404 1.9× 142 0.7× 187 1.1× 54 1.6k
Jung Hye Kim South Korea 17 459 0.9× 288 0.8× 89 0.4× 113 0.6× 271 1.6× 37 1.3k
E Zukowska-Szczechowska Poland 21 480 1.0× 321 0.9× 267 1.2× 180 0.9× 104 0.6× 95 1.5k
Evis Harja United States 17 595 1.2× 424 1.2× 94 0.4× 132 0.7× 198 1.2× 20 2.0k
Bryan R. Conway United Kingdom 20 422 0.8× 138 0.4× 451 2.1× 105 0.5× 98 0.6× 41 1.2k
Jan M. Williams United States 28 414 0.8× 543 1.6× 295 1.4× 90 0.5× 152 0.9× 83 1.9k

Countries citing papers authored by Julie E. Goodwin

Since Specialization
Citations

This map shows the geographic impact of Julie E. Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie E. Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie E. Goodwin more than expected).

Fields of papers citing papers by Julie E. Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie E. Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie E. Goodwin. The network helps show where Julie E. Goodwin may publish in the future.

Co-authorship network of co-authors of Julie E. Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Julie E. Goodwin. A scholar is included among the top collaborators of Julie E. Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie E. Goodwin. Julie E. Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tie‐Ning, Julie E. Goodwin, Ri Wen, et al.. (2025). Endothelial CLEC5A drives barrier dysfunction and vascular leakage responsible for lung injury in bacterial pneumonia and sepsis. Science Advances. 11(24). eadt7589–eadt7589. 4 indexed citations
2.
Srivastava, Swayam Prakash, Barani Kumar Rajendran, Masilamani Selvam, et al.. (2025). The molecular determinants regulating redox signaling in diabetic endothelial cells. Frontiers in Pharmacology. 16. 1563047–1563047. 2 indexed citations
3.
Afroz, Rizwana & Julie E. Goodwin. (2024). Wnt Signaling in Atherosclerosis: Mechanisms to Therapeutic Implications. Biomedicines. 12(2). 276–276. 3 indexed citations
4.
Srivastava, Swayam Prakash, Han Zhou, Begoña Lainez, et al.. (2024). Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease. Science Advances. 10(49). eadn6068–eadn6068. 8 indexed citations
5.
Gonzalez, Luis, Xin Li, Hualong Bai, et al.. (2024). Endothelial TGF-β Signaling Regulates Endothelial-Mesenchymal Transition During Arteriovenous Fistula Remodeling in Mice With Chronic Kidney Disease. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2509–2526. 8 indexed citations
6.
Akhter, Mohammad S. & Julie E. Goodwin. (2023). Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling. International Journal of Molecular Sciences. 24(18). 14261–14261. 4 indexed citations
7.
Srivastava, Swayam Prakash, Han Zhou, Ocean Setia, et al.. (2021). Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nature Communications. 12(1). 2368–2368. 89 indexed citations
8.
Liu, Bing, Han Zhou, Tie‐Ning Zhang, et al.. (2021). Loss of endothelial glucocorticoid receptor promotes angiogenesis via upregulation of Wnt/β-catenin pathway. Angiogenesis. 24(3). 631–645. 23 indexed citations
9.
Srivastava, Swayam Prakash, Arvind K. Srivastava, Subhash Chand, & Julie E. Goodwin. (2021). Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals. 14(8). 751–751. 14 indexed citations
10.
Srivastava, Swayam Prakash, Jinpeng Li, Yuta Takagaki, et al.. (2021). Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience. 24(5). 102390–102390. 51 indexed citations
11.
Srivastava, Swayam Prakash, Julie E. Goodwin, Keizo Kanasaki, & Daisuke Koya. (2020). Metabolic reprogramming by N‐acetyl‐seryl‐aspartyl‐lysyl‐proline protects against diabetic kidney disease. British Journal of Pharmacology. 177(16). 3691–3711. 47 indexed citations
12.
Srivastava, Swayam Prakash, Keizo Kanasaki, & Julie E. Goodwin. (2020). Loss of Mitochondrial Control Impacts Renal Health. Frontiers in Pharmacology. 11. 543973–543973. 26 indexed citations
13.
Zhou, Han, Sameet Mehta, Swayam Prakash Srivastava, et al.. (2020). Endothelial cell–glucocorticoid receptor interactions and regulation of Wnt signaling. JCI Insight. 5(3). 32 indexed citations
14.
Ayoob, Rose, John Barcia, Aftab S. Chishti, et al.. (2020). Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study. Frontiers in Pediatrics. 7. 550–550. 22 indexed citations
15.
Zhang, Tie‐Ning, Julie E. Goodwin, Bing Liu, et al.. (2019). Characterization of Long Noncoding RNA and mRNA Profiles in Sepsis-Induced Myocardial Depression. Molecular Therapy — Nucleic Acids. 17. 852–866. 38 indexed citations
16.
Srivastava, Swayam Prakash, Jinpeng Li, Munehiro Kitada, et al.. (2018). SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis. Cell Death and Disease. 9(10). 997–997. 132 indexed citations
17.
Goodwin, Julie E.. (2015). Glucocorticoids and the Cardiovascular System. Advances in experimental medicine and biology. 872. 299–314. 13 indexed citations
18.
Goodwin, Julie E., Yan Feng, Heino Velázquez, & William C. Sessa. (2012). Endothelial glucocorticoid receptor is required for protection against sepsis. Proceedings of the National Academy of Sciences. 110(1). 306–311. 114 indexed citations
19.
Goodwin, Julie E., Junhui Zhang, Heino Velázquez, & David S. Geller. (2010). The glucocorticoid receptor in the distal nephron is not necessary for the development or maintenance of dexamethasone-induced hypertension. Biochemical and Biophysical Research Communications. 394(2). 266–271. 21 indexed citations
20.
Zhang, Junhui, Catherine Matte-Martone, Julie E. Goodwin, et al.. (2008). Characterization of a Novel Gain of Function Glucocorticoid Receptor Knock-in Mouse. Journal of Biological Chemistry. 284(10). 6249–6259. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenguang Feng Breakdown of academic impact, for papers by Guijun Qin Breakdown of academic impact, for papers by Michiaki Abe Breakdown of academic impact, for papers by Ling Yu Breakdown of academic impact, for papers by Jung Hye Kim Breakdown of academic impact, for papers by E Zukowska-Szczechowska Breakdown of academic impact, for papers by Evis Harja Breakdown of academic impact, for papers by Bryan R. Conway Breakdown of academic impact, for papers by Jan M. Williams
Rankless by CCL
2026